XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,723,371 | -17.6% | 255,368 | -7.2% | 0.00% | 0.0% |
Q2 2023 | $10,590,580 | +3.7% | 275,080 | -3.6% | 0.00% | 0.0% |
Q1 2023 | $10,215,289 | -8.6% | 285,423 | +0.7% | 0.00% | -33.3% |
Q4 2022 | $11,180,022 | -33.4% | 283,541 | -39.1% | 0.00% | -25.0% |
Q3 2022 | $16,796,000 | +86.3% | 465,265 | +57.0% | 0.00% | +100.0% |
Q2 2022 | $9,014,000 | -59.3% | 296,314 | -59.1% | 0.00% | -60.0% |
Q1 2022 | $22,143,000 | +313.6% | 724,337 | +322.6% | 0.01% | +400.0% |
Q4 2021 | $5,354,000 | +265.0% | 171,394 | +78.6% | 0.00% | – |
Q3 2021 | $1,467,000 | -48.2% | 95,985 | -36.9% | 0.00% | -100.0% |
Q2 2021 | $2,834,000 | +17.1% | 152,218 | +12.6% | 0.00% | 0.0% |
Q1 2021 | $2,420,000 | +14.0% | 135,219 | -2.0% | 0.00% | 0.0% |
Q4 2020 | $2,122,000 | +209.3% | 137,961 | +122.6% | 0.00% | – |
Q3 2020 | $686,000 | +86.9% | 61,966 | +111.7% | 0.00% | – |
Q2 2020 | $367,000 | +115.9% | 29,272 | +126.3% | 0.00% | – |
Q4 2019 | $170,000 | +78.9% | 12,937 | +22.9% | 0.00% | – |
Q3 2019 | $95,000 | -23.4% | 10,529 | -14.0% | 0.00% | – |
Q1 2019 | $124,000 | +55.0% | 12,246 | -3.3% | 0.00% | – |
Q4 2018 | $80,000 | -60.4% | 12,663 | +5.5% | 0.00% | – |
Q1 2015 | $202,000 | -50.9% | 11,999 | -42.3% | 0.00% | – |
Q4 2014 | $411,000 | – | 20,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |